Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03012958 · ClinicalTrials.gov registry record
Utility of Lung Clearance Index Score as a Noninvasive Marker of Deployment Lung Disease
A clinical trial of Dyspnea and Bronchiolitis, sponsored by National Jewish Health.
- Completed
- Registry status
- 73
- Enrollment target
- 1
- Study location
NCT03012958 is a study of Dyspnea and Bronchiolitis that has completed, run by National Jewish Health. The registered enrollment target is 73 participants, below the 302-participant average among 23 other Dyspnea trials with a reported enrollment target (76% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03012958, a study of Dyspnea and Bronchiolitis, has completed, sponsored by National Jewish Health.
- COMPLETED
- Registry status
- 73 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to learn more about new noninvasive ways of detecting lung disease in US Military personnel and people who worked as contractors during military operations in Iraq and Afghanistan. This study is looking at conducting a type of breathing test called the lung clearance index (LCI) test which is being investigated as a potential noninvasive way to detect the type of lung disease that may be seen in symptomatic deployers retuning from Iraq and Afghanistan.
Conditions Studied
Interventions
- OTHER Lung clearance index (LCI)
Study Locations (1)
Colorado
- National Jewish Health - Denver
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 73 participants |
| Start Date | 2014-07 |
| Est. Completion | 2018-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03012958
The ClinicalTrials.gov registry entry for NCT03012958 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 73 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 302-participant average among 23 other Dyspnea trials with a reported enrollment target (76% lower). The listed sponsor is National Jewish Health, which has 83 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Dyspnea appearing as the primary indexed condition, and to 1 intervention - of which Lung clearance index (LCI) is the first listed.
NCT03012958 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.
Frequently Asked Questions
What is clinical trial NCT03012958 about?
NCT03012958 is a clinical study titled "Utility of Lung Clearance Index Score as a Noninvasive Marker of Deployment Lung Disease". The purpose of this study is to learn more about new noninvasive ways of detecting lung disease in US Military personnel and people who worked as contractors during military operations in Iraq and Afghanistan. This study is looking at conducting a type of breathing test called the lung clearance ind...
What is the current status of trial NCT03012958?
This trial is currently completed. The enrollment target is 73 participants. The study started on 2014-07. Estimated completion is 2018-05.
What conditions does trial NCT03012958 study?
This clinical trial studies the following conditions: Dyspnea, Bronchiolitis, Pneumonitis.
What interventions are being tested in trial NCT03012958?
The interventions under investigation include: Lung clearance index (LCI) (OTHER).
Who is sponsoring clinical trial NCT03012958?
This trial is sponsored by National Jewish Health, which has 83 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03012958 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Dyspnea
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
129Xe MRI Cardiopulmonary
RECRUITING · Phase 2
-
Structured Personalized Oxygen and Supportive Therapies for Dyspnea in Oncology
RECRUITING · Phase 2
-
The Increase of Lung Capacity Using the Lung Master (Pulmonary Exerciser)
RECRUITING · NA
-
Ventilatory and Perfusion Abnormalities in Individuals With Post-Acute Sequelae of SARS-CoV-2 Infection
RECRUITING
-
Breathe Easier With Tadalafil Therapy for Dyspnea in COPD-PH
RECRUITING · Phase 2
-
Inspiratory Muscle Training for Breast Cancer Patients on Chemotherapy
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.